Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18 F-FDG PET/CT in early-stage non-small cell lung cancer

The low level of circulating tumor DNA (ctDNA) in the blood is a well-known challenge for the application of liquid biopsies in early-stage non-small cell lung cancer (NSCLC) management. Studies of metastatic NSCLC indicate that ctDNA levels are associated with tumor metabolic activity as measured b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMC cancer 2023-07, Vol.23 (1), p.646
Hauptverfasser:	Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!